State AL
Clinical Trials in Alabama
Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 158 actively recruiting studies with Alabama sites out of 158 registered in total. The busiest research areas in Alabama are Obesity, Ovarian Cancer, Prostate Cancer. Leading sponsors running trials in the state include University of Alabama at Birmingham, AstraZeneca, Pfizer. By stage, Alabama trials break down as Phase 1 (20), Phase 2 (43), Phase 3 (47), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Alabama
Frequently Asked Questions — Clinical Trials in Alabama
How many clinical trials are currently recruiting in Alabama?
ClinicalMetric currently tracks 158 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 158. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alabama?
Alabama hosts clinical trials across a broad range of medical conditions, including Obesity, Ovarian Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alabama?
To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Alabama
NCT07837973 Phase 2
Recruiting
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Condition
Overweight , Obesity
Enrollment
220 pts
Location
United States
Sponsor
Alveus Therapeutics, Inc.
NCT03151629 N/A
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Condition
Prostate Cancer
Enrollment
5,000 pts
Location
United States, Australia, Barbados
Sponsor
Prostate Cancer Clinical Trial
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT05618353 Phase 4
Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Condition
Coronary Artery Disease
Enrollment
700 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT03321045 EARLY_Phase 1
Recruiting
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab ...
Condition
Breast Cancer
Enrollment
10 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06442761 Phase 1
Recruiting
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Condition
Sickle Cell Disease
Enrollment
20 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT07724041 N/A
Recruiting
Feasibility of a Real-world, Financial Psycho-oncology Intervention to Address C...
Condition
Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06218199 Phase 4
Recruiting
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Condition
Heart Failure, Congestive
Enrollment
80 pts
Location
United States
Sponsor
Heart Center Research, LLC
NCT07651514 N/A
Recruiting
The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in Peo...
Condition
Poor Sleep Quality
Enrollment
50 pts
Location
United States
Sponsor
StudySetGo
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
NCT06760819 Phase 2
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) T...
Condition
Advanced Solid Tumors
Enrollment
111 pts
Location
United States, Australia, Canada
Sponsor
Bayer
NCT06961565 Phase 1
Recruiting
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Condition
NF1 Mutation
Enrollment
56 pts
Location
United States, Australia, South Korea
Sponsor
Pasithea Therapeutics Corp.
NCT06533345 N/A
Recruiting
VCOM Pain Free Research Collaborative
Condition
Chronic Pain
Enrollment
120 pts
Location
United States
Sponsor
Edward Via Virginia College of
NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participant...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
40 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT06873945 Phase 3
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop...
Condition
Alopecia Areata
Enrollment
674 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT06477172 N/A
Recruiting
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Condition
Post Procedural Erythema
Enrollment
500 pts
Location
United States, Canada
Sponsor
Acorn Biolabs Inc.
NCT07553637 Phase 2
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Condition
Treatment-resistant Depression (TRD)
Enrollment
178 pts
Location
United States, United Kingdom
Sponsor
Alto Neuroscience
NCT06852053 N/A
Recruiting
Application to Predict Neonatal Apnea With Bradycardia
Condition
Apnea Neonatal
Enrollment
25 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07232030 N/A
Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Fai...
Condition
Heart Failure
Enrollment
2,500 pts
Location
United States
Sponsor
CVRx, Inc.
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
NCT07113522 Phase 2
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Condition
Inflammatory Bowel Disease (IBD)
Enrollment
140 pts
Location
United States, Canada, Georgia
Sponsor
Mirador Therapeutics, Inc.
NCT07100990 Phase 3
Recruiting
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasm...
Condition
Optic Neuritis
Enrollment
382 pts
Location
United States
Sponsor
Mayo Clinic
NCT03816345 Phase 1
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Pa...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05853783 N/A
Recruiting
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Condition
Mouth Diseases
Enrollment
180 pts
Location
United States
Sponsor
Proteocyte Diagnostics Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology